Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
NB: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year 2019 Concepts
- B Cell Epitope Discovery and Mechanisms of Antibody-Mediated Protection
- Large-Scale T Cell Epitope Discovery
- Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms
- Immune Mechanisms at the Maternal-Fetal Interface
- High-Priority Immunology Grants
Fiscal Year 2019 Small Business Innovation Research (SBIR) Contract Solicitation Topics
- Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases
- Adjuvant Discovery for Vaccines and for Autoimmune and Allergic Diseases
- B Cell Receptor and T Cell Receptor Repertoire Computational Tools
- Development of Sample Sparing Assays
- Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models
B Cell Epitope Discovery and Mechanisms of Antibody-Mediated Protection
For the published broad agency announcement, see the May 22, 2018 solicitation, B-Cell Epitope Discovery and Mechanisms of Antibody Protection.
Large-Scale T Cell Epitope Discovery
For the published broad agency announcement, see the May 8, 2018 solicitation, Large-Scale T Cell Immune Epitope Discovery.
Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms
For the published program announcement with special receipt, referral, and/or review considerations, see the May 10, 2018 Guide announcement, Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21, Clinical Trial Not Allowed).
Immune Mechanisms at the Maternal-Fetal Interface
For the published request for applications, see the June 14, 2018 Guide announcement, Immune Mechanisms at the Maternal-Fetal Interface (R01, Clinical Trial Optional).
High-Priority Immunology Grants
For more information, see the March 28, 2018 Guide notice, Notice of NIAID's Interest in Continued Support of High-Priority Immunology Grants.
Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).(link is external)
Adjuvant Discovery for Vaccines and for Autoimmune and Allergic Diseases
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).
B Cell Receptor and T Cell Receptor Repertoire Computational Tools
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).
Development of Sample Sparing Assays
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).
Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models
For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).